53 related articles for article (PubMed ID: 15922873)
1. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle regulation by the B-Myb transcription factor.
Joaquin M; Watson RJ
Cell Mol Life Sci; 2003 Nov; 60(11):2389-401. PubMed ID: 14625684
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter.
De Haro L; Janknecht R
Nucleic Acids Res; 2002 Jul; 30(13):2972-9. PubMed ID: 12087183
[TBL] [Abstract][Full Text] [Related]
4. G-quadruplex forming motifs in the promoter region of the B-MYB proto-oncogene.
Miranda A; Cucchiarini A; Esnault C; Andrau JC; Oliveira PA; Mergny JL; Cruz C
Int J Biol Macromol; 2024 Jun; 270(Pt 1):132244. PubMed ID: 38729459
[TBL] [Abstract][Full Text] [Related]
5. B-MYB delays cell aging by repressing p16 (INK4α) transcription.
Huang Y; Wu J; Li R; Wang P; Han L; Zhang Z; Tong T
Cell Mol Life Sci; 2011 Mar; 68(5):893-901. PubMed ID: 20734103
[TBL] [Abstract][Full Text] [Related]
6. A-MYB substitutes for B-MYB in activating cell cycle genes and in stimulating proliferation.
Kohler R; Engeland K
Nucleic Acids Res; 2024 May; ():. PubMed ID: 38747345
[TBL] [Abstract][Full Text] [Related]
7.
Guo H; Li N; Sun Y; Wu C; Deng H; Xu L; Yang X
Front Oncol; 2021; 11():734588. PubMed ID: 34568071
[TBL] [Abstract][Full Text] [Related]
8. MYB oncoproteins: emerging players and potential therapeutic targets in human cancer.
Cicirò Y; Sala A
Oncogenesis; 2021 Feb; 10(2):19. PubMed ID: 33637673
[TBL] [Abstract][Full Text] [Related]
9. Resistin: An inflammatory cytokine with multi-faceted roles in cancer.
Sudan SK; Deshmukh SK; Poosarla T; Holliday NP; Dyess DL; Singh AP; Singh S
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188419. PubMed ID: 32822824
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin L induced PC-12 cell apoptosis via activation of B-Myb and regulation of cell cycle proteins.
Shen X; Zhao YF; Xu SQ; Wang L; Cao HM; Cao Y; Zhu Y; Wang Y; Liang ZQ
Acta Pharmacol Sin; 2019 Nov; 40(11):1394-1403. PubMed ID: 31444477
[TBL] [Abstract][Full Text] [Related]
11. MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.
Musa J; Aynaud MM; Mirabeau O; Delattre O; Grünewald TG
Cell Death Dis; 2017 Jun; 8(6):e2895. PubMed ID: 28640249
[TBL] [Abstract][Full Text] [Related]
12. B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer.
Jin Y; Zhu H; Cai W; Fan X; Wang Y; Niu Y; Song F; Bu Y
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555007
[TBL] [Abstract][Full Text] [Related]
13. Situational awareness: regulation of the myb transcription factor in differentiation, the cell cycle and oncogenesis.
George OL; Ness SA
Cancers (Basel); 2014 Oct; 6(4):2049-71. PubMed ID: 25279451
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor-pathway coexpression analysis reveals cooperation between SP1 and ESR1 on dysregulating cell cycle arrest in non-hyperdiploid multiple myeloma.
Wang X; Yan Z; Fulciniti M; Li Y; Gkotzamanidou M; Amin SB; Shah PK; Zhang Y; Munshi NC; Li C
Leukemia; 2014 Apr; 28(4):894-903. PubMed ID: 23925045
[TBL] [Abstract][Full Text] [Related]
15. Cyclin d1 downregulation contributes to anticancer effect of isorhapontigenin on human bladder cancer cells.
Fang Y; Cao Z; Hou Q; Ma C; Yao C; Li J; Wu XR; Huang C
Mol Cancer Ther; 2013 Aug; 12(8):1492-503. PubMed ID: 23723126
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the transactivation domain of B-Myb with the TAZ2 domain of the coactivator p300: molecular features and properties of the complex.
Oka O; Waters LC; Strong SL; Dosanjh NS; Veverka V; Muskett FW; Renshaw PS; Klempnauer KH; Carr MD
PLoS One; 2012; 7(12):e52906. PubMed ID: 23300815
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 rare variants in UK multiple adenoma and early-onset colorectal cancer patients.
Bonilla C; Lefèvre JH; Winney B; Johnstone E; Tonks S; Colas C; Day T; Hutnik K; Boumertit A; Midgley R; Kerr D; Parc Y; Bodmer WF
J Hum Genet; 2011 Jan; 56(1):58-63. PubMed ID: 21107342
[TBL] [Abstract][Full Text] [Related]
18. MYBL2, a link between proliferation and differentiation in maturing colon epithelial cells.
Papetti M; Augenlicht LH
J Cell Physiol; 2011 Mar; 226(3):785-91. PubMed ID: 20857481
[TBL] [Abstract][Full Text] [Related]
19. Stem cell pluripotency: a cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle.
Boheler KR
J Cell Physiol; 2009 Oct; 221(1):10-7. PubMed ID: 19562686
[TBL] [Abstract][Full Text] [Related]
20. Diazoxide-mediated growth inhibition in human lung cancer cells via downregulation of beta-catenin-mediated cyclin D1 transcription.
Ding J; Ge D; Guo W; Lu C
Lung; 2009; 187(1):61-7. PubMed ID: 19052819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
